Group 2001–2005 (N = 465) | Group 2006–2010 (N = 405) | |||||
---|---|---|---|---|---|---|
χ 2 | Cramer’s V | χ 2 | Cramer’s V | |||
End of the treatment | ||||||
MDE (past) | 47.2 (64.7) | 13.27*** | 0.17 | 44.1 (58.9) | 8.85** | 0.15 |
MDE (current) | 31.6 (61.1) | 12.56*** | 0.16 | 40.0 (53.2) | 2.25 | |
Depressive disorder (past) | 46.0 (63.4) | 11.45** | 0.16 | 44.0 (56.9) | 6.26* | 0.12 |
Depressive disorder (current) | 31.8 (61.5) | 14.50*** | 0.18 | 50.9 (52.3) | 0.04 | |
6-month follow-up | ||||||
MDE (past) | 25.2 (33.7) | 3.55 | 22.0 (26.0) | 0.87 | ||
MDE (current) | 13.2 (32.3) | 6.02* | 0.11 | 28.6 (23.8) | 0.40 | |
Depressive disorder (past) | 25.4 (32.7) | 2.33 | 19.3 (27.1) | 3.07 | ||
Depressive disorder (current) | 6.8 (33.3) | 13.07*** | 0.17 | 17.5 (25.3) | 1.60 | |
12-month follow-up | ||||||
MDE (past) | 20.1 (31.4) | 6.63* | 0.12 | 19.9 (23.7) | 0.87 | |
MDE (current) | 7.9 (29.3) | 7.99** | 0.13 | 17.1 (22.4) | 0.52 | |
Depressive disorder (past) | 23.0 (29.2) | 1.76 | 18.0 (24.3) | 2.19 | ||
Depressive disorder (current) | 9.1 (29.5) | 8.28** | 0.13 | 15.8 (23.0) | 1.48 |